Exane BNP Paribas Initiates Coverage On Monster Beverage with Underperform Rating, Announces Price Target of $48
Portfolio Pulse from Benzinga Newsdesk
Exane BNP Paribas has initiated coverage on Monster Beverage (NASDAQ:MNST) with an Underperform rating and set a price target of $48.
June 24, 2024 | 10:38 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Exane BNP Paribas has initiated coverage on Monster Beverage with an Underperform rating and a price target of $48, suggesting potential downside.
The Underperform rating and the price target of $48, which is below the current trading price, indicate a bearish outlook from Exane BNP Paribas. This could lead to a negative sentiment among investors and potential short-term price decline.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100